Global evidence on what it costs to conduct a campaign is limited, and cost evidence on integrated campaigns is virtually non-existent. To address these issues, and to inform methodological guidance on immunization costing, ThinkWell has conducted two costing studies around integrated campaigns: Sierra Leone delivered MR, OPV, Vitamin A and deworming tablets, and a yellow fever campaign in Nigeria which was partially integrated with Meningitis A vaccine. Early findings show efficiencies in major financial cost drivers such as per diem and transport cost, but also highlight the importance of the existing All people engaged in actions whose primary intent is to enhance health. in delivering integrated campaigns.
The discussion was led by Laura Boonstoppel, Program Manager at ThinkWell. Laura is a senior economist with 10+ years of experience in global health, health The resources required to deliver public health functions to populations, the impact of those resources on the health of those populations,2 and the impact on the public health sys, and development economics. At ThinkWell, she is currently the project director for the Economics of Last Mile Delivery Hub, and has previously led other immunization costing projects, allocative The ability of campaign-delivered interventions to achieve higher levels of performance (coverage, quality, or equity) relative to the inputs (resources, time, money) analyses, health labor market analyses, and contributed to strategic purchasing projects for TB and family planning. She holds a MSc in economics from the University of Geneva, and a BSc in economics and business economics from the VU University in Amsterdam.